Raziye Piranlioglu

951 citations
13 papers · 517 indexed · h-index 9
Topics
Immune cells in cancer (5 papers)Cancer Cells and Metastasis (4 papers)Virus-based gene therapy research (3 papers)
Partner nations
United StatesItalyFrance

In The Last Decade

Raziye Piranlioglu

12 papers receiving 511 citations

Peers

Raziye Piranlioglu
Comparison fields: 5 of 65
  • Immunology 276
  • Oncology 251
  • Molecular Biology 199
  • Cancer Research 92
  • Biomedical Engineering 57
Replace Carol Cao with:
Carol Cao United States
Qizhi Ma China
Feyza Gül Özbay Kurt Germany
Vanessa F. Boura Sweden
Lukas W. Pfannenstiel United States
Yulei Chen China
Claire Banissi France
Rosa E. Menjivar United States
Emily N. Arner United States
Linda Ziani France
Raziye Piranlioglu relative to Carol Cao United States Carol Cao's profile →
Citations per field
00.5×6.8×
Carol Cao · 1×
Citations per year

Countries citing papers authored by Raziye Piranlioglu

Since Specialization
Citations

This map shows the geographic impact of Raziye Piranlioglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raziye Piranlioglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raziye Piranlioglu more than expected).

Fields of papers citing papers by Raziye Piranlioglu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raziye Piranlioglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raziye Piranlioglu. The network helps show where Raziye Piranlioglu may publish in the future.

Co-authorship network of co-authors of Raziye Piranlioglu

This figure shows the co-authorship network connecting the top 25 collaborators of Raziye Piranlioglu. A scholar is included among the top collaborators of Raziye Piranlioglu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raziye Piranlioglu. Raziye Piranlioglu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 1
2 2
3 0
4 8
5 12
6 10
7 21
8 58
9 76
10 11
11 30
12 287
13 1

About Raziye Piranlioglu

Raziye Piranlioglu is a scholar working on Immunology, Biological Psychiatry and Oncology, having authored 13 papers that have together received 517 indexed citations. Recurring topics across this work include Immune cells in cancer (5 papers), Cancer Cells and Metastasis (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Immunology (276 citations), Oncology (251 citations) and Cancer Research (92 citations). Raziye Piranlioglu has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Hasan Körkaya, Ali S. Arbab, Maria Ouzounova, Ahmed Chadli, John K. Cowell, Khaled A. Hassan, Daniela Marasco, Eunmi Lee, Gang Zhou and Abdeljabar El Andaloussi. Their work appears in journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026